Abstract

Large-scale meta-analyses of genome-wide association studies have recently confirmed that the rs340874 single-nucleotide polymorphism in PROX1 gene is associated with fasting glycemia and type 2 diabetes mellitus; however, the mechanism of this link was not well established. The aim of our study was to evaluate the functional/phenotypic differences related to rs340874 PROX1 variants. The study group comprised 945 subjects of Polish origin (including 634 with BMI > 25) without previously known dysglycemia. We analyzed behavioral patterns (diet, physical activity), body fat distribution and glucose/fat metabolism after standardized meals and during the oral glucose tolerance test. We found that the carriers of the rs340874 PROX1 CC genotype had higher nonesterified fatty acids levels after high-fat meal (p = 0.035) and lower glucose oxidation (p = 0.014) after high-carbohydrate meal in comparison with subjects with other PROX1 genotypes. Moreover, in subjects with CC variant, we found higher accumulation of visceral fat (p < 0.02), but surprisingly lower daily food consumption (p < 0.001). We hypothesize that lipid metabolism alterations in subjects with the PROX1 CC genotype may be a primary cause of higher glucose levels after glucose load, since the fatty acids can inhibit insulin-stimulated glucose uptake by decreasing carbohydrate oxidation. Our observations suggest that the PROX1 variants have pleiotropic effect on disease pathways and it seem to be a very interesting goal of research on prevention of obesity and type 2 diabetes mellitus. The study may help to understand the mechanisms of visceral obesity and type 2 diabetes mellitus risk development.

Highlights

  • The large meta-analyses of genome-wide association studies have confirmed that the rs340874 single-nucleotide polymorphism (SNP) in PROX1 gene is associated with fasting glycemia and type 2 diabetes mellitus (Dupuis et al 2010; DIAGRAM Consortium et al 2014)

  • We found that the carriers of the rs340874 PROX1 CC genotype had higher nonesterified fatty acids levels after high-fat meal (p = 0.035) and lower glucose oxidation (p = 0.014) after high-carbohydrate meal in comparison with subjects with other PROX1 genotypes

  • We showed for the first time that the association of the rs340874 C allele with type 2 diabetes mellitus can be related to the nonesterified fatty acids (NEFAs)/glucose metabolism alterations

Read more

Summary

Introduction

The large meta-analyses of genome-wide association studies have confirmed that the rs340874 single-nucleotide polymorphism (SNP) in PROX1 gene is associated with fasting glycemia and type 2 diabetes mellitus (Dupuis et al 2010; DIAGRAM Consortium et al 2014). PROX1 is a transcription factor that plays a key regulatory role in neurogenesis and embryonic development of the pancreas, liver, heart and lymphatic system (Takeda and Jetten 2013; http://www.genecards.org). There is growing evidence based on animal model studies that PROX1 can play crucial role in the glucose/lipid metabolism in liver (Harvey et al 2005). PROX1 can activate transcription or function as a corepressor of wide range of genes regulating physiological processes, including HNF4a and acid-related orphan receptors (RORa and RORc) involved in the regulation of various metabolic genes (Takeda and Jetten 2013; Jetten et al 2013; Hayhurst et al 2001)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call